These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

456 related items for PubMed ID: 16120153

  • 1. Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus.
    Arin MJ, Engert A, Krieg T, Hunzelmann N.
    Br J Dermatol; 2005 Sep; 153(3):620-5. PubMed ID: 16120153
    [Abstract] [Full Text] [Related]

  • 2. Treatment of refractory pemphigus with the anti-CD20 monoclonal antibody (rituximab).
    Marzano AV, Fanoni D, Venegoni L, Berti E, Caputo R.
    Dermatology; 2007 Sep; 214(4):310-8. PubMed ID: 17460402
    [Abstract] [Full Text] [Related]

  • 3. Two courses of rituximab (anti-CD20 monoclonal antibody) for recalcitrant pemphigus vulgaris.
    Faurschou A, Gniadecki R.
    Int J Dermatol; 2008 Mar; 47(3):292-4. PubMed ID: 18289336
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Therapy of refractory pemphigus vulgaris with monoclonal anti-CD20 antibody (rituximab).
    Morrison LH.
    J Am Acad Dermatol; 2004 Nov; 51(5):817-9. PubMed ID: 15523367
    [Abstract] [Full Text] [Related]

  • 7. Successful treatment of refractory childhood pemphgus vulgaris with anti-CD20 monoclonal antibody (rituximab).
    Kong HH, Prose NS, Ware RE, Hall RP.
    Pediatr Dermatol; 2005 Nov; 22(5):461-4. PubMed ID: 16191003
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A single cycle of rituximab for the treatment of severe pemphigus.
    Joly P, Mouquet H, Roujeau JC, D'Incan M, Gilbert D, Jacquot S, Gougeon ML, Bedane C, Muller R, Dreno B, Doutre MS, Delaporte E, Pauwels C, Franck N, Caux F, Picard C, Tancrede-Bohin E, Bernard P, Tron F, Hertl M, Musette P.
    N Engl J Med; 2007 Aug 09; 357(6):545-52. PubMed ID: 17687130
    [Abstract] [Full Text] [Related]

  • 10. Treatment of refractory pemphigus vulgaris with rituximab (anti-CD20 monoclonal antibody).
    Dupuy A, Viguier M, Bédane C, Cordoliani F, Blaise S, Aucouturier F, Bonnetblanc JM, Morel P, Dubertret L, Bachelez H.
    Arch Dermatol; 2004 Jan 09; 140(1):91-6. PubMed ID: 14732665
    [Abstract] [Full Text] [Related]

  • 11. Rituximab: a monoclonal antibody to CD20 used in the treatment of pemphigus vulgaris.
    El Tal AK, Posner MR, Spigelman Z, Ahmed AR.
    J Am Acad Dermatol; 2006 Sep 09; 55(3):449-59. PubMed ID: 16908351
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Long-term observation of patients with anti-neutrophil cytoplasmic antibody-associated vasculitis treated with rituximab.
    Stasi R, Stipa E, Del Poeta G, Amadori S, Newland AC, Provan D.
    Rheumatology (Oxford); 2006 Nov 09; 45(11):1432-6. PubMed ID: 16632482
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. The efficacy and safety of rituximab in refractory pemphigus: a review of case reports.
    Allen KJ, Wolverton SE.
    J Drugs Dermatol; 2007 Sep 09; 6(9):883-9. PubMed ID: 17941359
    [Abstract] [Full Text] [Related]

  • 16. Treatment of severe pemphigus with protein A immunoadsorption, rituximab and intravenous immunoglobulins.
    Shimanovich I, Nitschke M, Rose C, Grabbe J, Zillikens D.
    Br J Dermatol; 2008 Feb 09; 158(2):382-8. PubMed ID: 18070210
    [Abstract] [Full Text] [Related]

  • 17. Rituximab in childhood pemphigus vulgaris: a long-term follow-up case and review of the literature.
    Fuertes I, Guilabert A, Mascaró JM, Iranzo P.
    Dermatology; 2010 Aug 09; 221(1):13-6. PubMed ID: 20389028
    [Abstract] [Full Text] [Related]

  • 18. Recommendations for the use of rituximab (anti-CD20 antibody) in the treatment of autoimmune bullous skin diseases.
    Hertl M, Zillikens D, Borradori L, Bruckner-Tuderman L, Burckhard H, Eming R, Engert A, Goebeler M, Hofmann S, Hunzelmann N, Karlhofer F, Kautz O, Lippert U, Niedermeier A, Nitschke M, Pfütze M, Reiser M, Rose C, Schmidt E, Shimanovich I, Sticherling M, Wolff-Franke S.
    J Dtsch Dermatol Ges; 2008 May 09; 6(5):366-73. PubMed ID: 18201220
    [Abstract] [Full Text] [Related]

  • 19. Low-dose rituximab is effective in pemphigus.
    Horváth B, Huizinga J, Pas HH, Mulder AB, Jonkman MF.
    Br J Dermatol; 2012 Feb 09; 166(2):405-12. PubMed ID: 21967609
    [Abstract] [Full Text] [Related]

  • 20. Rituximab in the adjuvant treatment of pemphigus vulgaris: a prospective open-label pilot study in five patients.
    Goh MS, McCormack C, Dinh HV, Welsh B, Foley P, Prince HM.
    Br J Dermatol; 2007 May 09; 156(5):990-6. PubMed ID: 17355229
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.